MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,915 | +9.6% | 2,684 | -9.1% | 0.07% | +12.7% |
| Q2 2023 | $106,656 | +23.8% | 2,952 | +27.4% | 0.06% | +34.0% |
| Q1 2023 | $86,183 | -40.6% | 2,318 | -27.6% | 0.05% | -38.2% |
| Q4 2022 | $145,128 | +4.4% | 3,203 | +61.0% | 0.08% | +38.2% |
| Q3 2022 | $139,000 | +4.5% | 1,989 | +0.7% | 0.06% | +12.2% |
| Q2 2022 | $133,000 | +44.6% | 1,975 | +77.3% | 0.05% | +19.5% |
| Q1 2022 | $92,000 | -47.1% | 1,114 | -5.8% | 0.04% | -37.9% |
| Q4 2021 | $174,000 | -21.3% | 1,183 | -5.3% | 0.07% | -32.0% |
| Q3 2021 | $221,000 | +3.8% | 1,249 | -5.2% | 0.10% | +10.2% |
| Q2 2021 | $213,000 | -2.7% | 1,318 | +3.1% | 0.09% | -4.3% |
| Q1 2021 | $219,000 | -20.7% | 1,278 | +1.8% | 0.09% | -20.0% |
| Q4 2020 | $276,000 | -44.9% | 1,256 | -58.4% | 0.12% | -56.3% |
| Q3 2020 | $501,000 | +28.1% | 3,020 | -11.8% | 0.26% | +42.2% |
| Q2 2020 | $391,000 | +58.3% | 3,424 | +6.6% | 0.18% | +81.4% |
| Q1 2020 | $247,000 | -47.9% | 3,211 | -12.7% | 0.10% | +32.5% |
| Q4 2019 | $474,000 | +125.7% | 3,678 | +36.7% | 0.08% | +83.3% |
| Q3 2019 | $210,000 | -28.1% | 2,690 | -5.2% | 0.04% | -32.3% |
| Q2 2019 | $292,000 | -38.8% | 2,839 | -56.4% | 0.06% | -93.9% |
| Q1 2019 | $477,000 | +54.4% | 6,506 | -10.7% | 1.02% | +1815.1% |
| Q4 2018 | $309,000 | -31.5% | 7,284 | -23.9% | 0.05% | +12.8% |
| Q3 2018 | $451,000 | -44.3% | 9,575 | -41.7% | 0.05% | -93.4% |
| Q2 2018 | $810,000 | -38.8% | 16,429 | -61.9% | 0.72% | -37.7% |
| Q1 2018 | $1,324,000 | +266.8% | 43,136 | +118.0% | 1.15% | +153.6% |
| Q4 2017 | $361,000 | +114.9% | 19,786 | +152.8% | 0.45% | +96.1% |
| Q1 2016 | $168,000 | – | 7,828 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |